![Charles Swanton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Swanton
Directeur/Bestuurslid bij
NOVARTIS AG
Vermogen: 65 064 $ op 31-07-2026
Profiel
Charles Swanton is the founder of Achilles Therapeutics Plc, founded in 2020, with no titles listed.
Dr. Swanton is the founder of Achilles Therapeutics UK Ltd., founded in 2016, with no titles listed.
Dr. Swanton is the founder of The Francis Crick Institute Ltd., founded in 2016, holding the title of Deputy Director-Clinical since 2023.
Dr. Swanton is also the founder of University College London.
Current jobs include Director at American Association for Cancer Research since 2019 and Director at Novartis AG starting in 2026.
Former jobs include Co-Director-Lung Cancer Centre of Excellence at Cancer Research UK, Director at Bicycle Therapeutics Plc from 2025 to 2026, and a position at UCL Medical School.
Education includes undergraduate studies at UCL Medical School and both undergraduate and doctorate degrees from University College London.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 13-04-2026 | 16.856 ( 0,04% ) | 65 064 $ | 31-07-2026 |
Actieve functies van Charles Swanton
| Bedrijven | Functie | Begin |
|---|---|---|
| NOVARTIS AG | Directeur/Bestuurslid | 06-03-2026 |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Directeur/Bestuurslid | 01-01-2019 |
The Francis Crick Institute Ltd.
 The Francis Crick Institute Ltd. Investment Trusts/Mutual FundsMiscellaneous Operates as an independent charity that engages in biomedicine research | Oprichter | - |
Eerdere bekende functies van Charles Swanton
| Bedrijven | Functie | Einde |
|---|---|---|
| BICYCLE THERAPEUTICS PLC | Directeur/Bestuurslid | 18-08-2026 |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Oprichter | 01-01-2025 |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Oprichter | - |
Cancer Research UK
 Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Provides cancer research services | Corporate Officer/Principal | - |
| ACHILLES THERAPEUTICS PLC | Oprichter | - |
Opleiding van Charles Swanton
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
87
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cancer Research UK
Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Provides cancer research services | Commercial Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer | Commercial Services |
Bicycle Therapeutics Plc
 Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
The Francis Crick Institute Ltd.
The Francis Crick Institute Ltd. Investment Trusts/Mutual FundsMiscellaneous Operates as an independent charity that engages in biomedicine research | Miscellaneous |
UCL Medical School
 UCL Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Health Technology |
Achilles Therapeutics Plc
 Achilles Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and sells cancer immunotherapies | Health Technology |
